Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Target-oriented Vitamin D in Refractory Crohn's Disease
NCT04134065Phase 1Unknown
- Sponsor
- Nanjing University School of Medicine
- Start
- Dec 2019
- Primary completion
- Oct 2020
- Modality
- Orthosteric Ligands, Metabolically Activated Prodrugs
01
Overview
Phase 1, randomised, double-blind trial of vitamin d in Crohn's disease (2 arms), sponsored by Nanjing University School of Medicine. Primary endpoints: Clinical Disease Activity Index at 1 year, Fecal calprotectin at 1 year and 3 more. Status: unknown.
02
Drugs
vitamin d
03
Conditions
Crohn's disease
Beyond the preview
Go deeper on NCT04134065.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04134065.